OR WAIT null SECS
May 04, 2016
ANSM lifted the suspension on Catalent’s Beinheim, France facility, allowing the company to resume pharmaceutical operations.
May 03, 2016
The companies have agreed to an all-stock merger of equals transaction anticipated to close in the second half of 2016.
April 28, 2016
AbbVie will acquire Stemcentrx and its lead late-stage asset rovalpituzumab tesirine (Rova-T), a novel biomarker-specific therapy derived from cancer stem cells.
April 25, 2016
WHO report highlights goal of eliminating malaria in 35 countries by 2030.
April 20, 2016
Pfizer announced the launch of Pfizer CentreOne, a CMO formed by the combination of Pfizer CentreSource and Hospira One 2 One.
The National Institutes of Health (NIH) released a statement on April 19, 2016 saying that it plans to suspend research in two laboratories after preliminary results found the labs not in compliance with CGMP practices.
Traditional methods of measuring the effectiveness of vaccines against the flu are called into question by new findings from the NIH.
April 14, 2016
The IMS Institute for Healthcare Informatics report examines spending on medicine in the US, drivers of growth, major market segments, prescription volume, patient costs, and healthcare delivery changes.
April 13, 2016
The conference will take place from May 16–18, 2017 in Philadelphia, Pennsylvania.
April 11, 2016
Cornell researchers reveal that an existing FDA-approved drug can facilitate the delivery of other large molecules across the blood-brain barrier.